超越普通:一种非典型的吉兰-巴雷综合征病例,具有独特的特征
Victor D Acuña-Rocha1, Luis A González-Torres1, Claudia E Gómez-Hernández2
1Department of Internal Medicine, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, MEX.
Cureus
|September 25, 2023
概括
本案例研究描述了一种罕见的喉 - 宫 - 臂部吉兰 - 巴雷综合征 (PCB-GBS) 变体,其进展和恢复很快. 早期诊断和等离子体合成导致完全康复,强调了识别罕见GBS呈现的重要性.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
背景情况:
- 吉兰-巴雷综合征 (GBS) 是一种影响周围神经系统的自身免疫性疾病.
- 喉 - 宫 - 腕 (PCB) 变种的GBS是罕见的,并呈现出明显的神经缺陷.
更多相关视频
09:29Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
Published on: August 21, 2017
11.5K
08:16Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
Published on: March 4, 2014
31.9K
相关概念视频
Myasthenia Gravis: Diagnostic Tests
960
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
960
Myasthenia Gravis: Overview and Treatment
1.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.6K
